Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Investigator-initiated Translational Study Evaluating Individualized Treatment Regiments Based on Respective Biomarker Analyses for Refractory Leukemia and Lymphoma Patients

NCT03096821 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT03096821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03096821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Investigator-initiated Translational Study Evaluating Individualized Treatment Regiments Based on Respective Biomarker Analyses for Refractory Leukemia and Lymphoma Patients
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Completed
Start date
September 30, 2015
Completion date
January 30, 2020
Enrollment
143 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed hematologic malignancy